Edition:
United States

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

89.11EUR
24 May 2016
Change (% chg)

-- (--)
Prev Close
€89.11
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
556,784
52-wk High
€102.30
52-wk Low
€70.68

MRCG.DE

Chart for MRCG.DE

About

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of... (more)

Overall

Beta: 0.92
Market Cap(Mil.): €11,356.52
Shares Outstanding(Mil.): 129.24
Dividend: 1.05
Yield (%): 1.19

Financials

  MRCG.DE Industry Sector
P/E (TTM): 26.93 34.43 35.43
EPS (TTM): 3.26 -- --
ROI: 5.34 13.73 13.09
ROE: 10.81 14.71 14.22

BRIEF-Merck KGaA expects to file for first approval of Avelumab in H2

* CEO says expects to file for first approval of Avelumab in merkel cell carcinoma in H2 Further company coverage:

May 19 2016

Merck KGaA sees gain in adj EBITDA of up to 18.5 pct

FRANKFURT, May 19 German drugs and chemicals maker Merck KGaA expects adjusted core earnings to increase by up to 18.5 percent this year, helped by additional profit from a takeover of lab supplies maker Sigma-Aldrich.

May 19 2016

Germany's Merck says gene editing to help it outperform

DARMSTADT, Germany Germany's Merck KGaA, the world's second-largest supplier of materials and equipment to the biotech sector, expects to continue delivering market-beating sales growth, helped in part by new gene modification techniques.

May 13 2016

BRIEF-Merck sees negative FX effects for 2016

* Says sees significant nominal and slight organic growth in sales this year

Apr 29 2016

BRIEF-Merck KGaA selects Unisys to deliver global end-user IT services

* Merck kgaa selects unisys to deliver global end-user it services to support its growth strategy

Apr 26 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Pechala's Reports
$25.00
Provider : Finlabo SIM Spa
$10.00
Provider : Sadif Analytics Prime
$10.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.